Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Innovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing

Sunitha Nagrath's Biography



Sunitha Nagrath, Professor of Chemical Engineering and Biomedical Engineering, University of Michigan-Ann Arbor

Dr. Sunitha Nagrath is a Professor of Chemical Engineering and Biomedical Engineering at University of Michigan. Dr. Nagrath received her Ph.D. in 2004 from Rensselaer Polytechnic Institute, Troy, NY in Mechanical Engineering. She did her postdoctoral work at Harvard Medical/Massachusetts General Hospital, Boston, under the mentorship of Dr. Toner. Dr. Nagrath is the leading scientist who designed the MEMS based technology, “CTC-Chip” for the sensitive isolation of circulating tumor cells (CTCs) from the blood of cancer patients. She joined the University of Michigan in 2010 as a tenure track faculty, where she established her laboratory focused on engineering innovative microfluidic devices and nanomaterials for implementing personalized precision medicine via liquid biopsy. Dr. Nagrath’s major focus of research is on understanding cell trafficking in cancer through the isolation, characterization, and study of circulating cells and extracellular vesicles in the peripheral blood of cancer patients. She is a co-director of the Liquid Biopsy Shared Resource at UMICH Comprehensive Cancer Center, where she oversees the services of isolation and characterization of biomarkers and their implementation in clinical studies. She is an elected fellow of AIMBE and received several accolades including, Analytical Chemistry Young Innovator Award, and NIH Director’s New innovator award. Dr. Nagrath is the co-founder and the board member of Labyrinth Biotech, a biotechnology company commercializing some of the technologies that are developed in her lab.

Sunitha Nagrath Image

Welcome and Introduction by Conference Co-Chairpersons -- Scope of the Conference and Topics Covered

Monday, 6 May 2024 at 09:00

Add to Calendar ▼2024-05-07 14:00:002024-05-07 15:00:00Europe/LondonThe Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com

Micro Innovations Defining the New Frontiers of Liquid Biopsy

Tuesday, 7 May 2024 at 09:30

Add to Calendar ▼2024-05-07 14:00:002024-05-07 15:00:00Europe/LondonThe Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com

Microfluidic technologies were always at the forefront of innovations in liquid biopsies. There were several corner stone microfluidic technologies that enabled sensitive and yet specific identification of blood-based biomarkers. The confluence of technology advancement and rapid developments in molecular characterization techniques pushed the boundaries of liquid biopsies thus enhancing the clinical utility of blood biopsies. Several such key enabling technologies will be presented. How isolation of circulating tumor cells using novel microfluidic technologies can enable precision diagnostics will be demonstrated with the example clinical case studies.

The Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the Clinic

Tuesday, 7 May 2024 at 14:00

Add to Calendar ▼2024-05-07 14:00:002024-05-07 15:00:00Europe/LondonThe Next Big Small Things: Technology Driven Approaches to Bring Extracellular Vesicles into the ClinicInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com

Small nanoscale extracellular vesicles (EVs), known as exosomes, represent a rapidly emerging biomarker for cancer detection by liquid biopsy.  Given the tiny amount of cargo carried by these nano-sized vesicles, the development of techniques that can analyze these important carriers is an active area of research in recent times. Additionally, while high in information content, the current exosomes profiling protocols are lengthy, preventing their widespread utilization and cancer diagnostics in a timely manner.  Recent advances in technologies and approaches will be discussed to isolate and probe exosomes.  We present the isolation of tumor derived EVs and their molecular cargo for rapid cancer diagnosis and in-depth mutation profiling.


Add to Calendar ▼2024-05-06 00:00:002024-05-07 00:00:00Europe/LondonInnovations in Microfluidics 2024: Rapid Prototyping, 3D-PrintingInnovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing in Ann Arbor, MichiganAnn Arbor, MichiganSELECTBIOenquiries@selectbiosciences.com